Cerebral Vasospasm Market: Global Market Size, Share, Growth and Forecast to 2032
The Cerebral Vasospasm Market is gaining importance as healthcare providers focus on improving the diagnosis and management of cerebral vasospasm, particularly following subarachnoid hemorrhage. According to Market Research Future, the market was valued at approximately USD 2.41 billion in 2024 and is projected to reach USD 4.745 billion by 2035, expanding at a CAGR of 6.35% during 2025–2035.
The market is being supported by advancements in diagnostic imaging, innovative treatment approaches, and increasing awareness among healthcare professionals. Diagnostic modalities include computed tomography angiography, digital subtraction angiography, magnetic resonance angiography, and transcranial Doppler. Digital subtraction angiography currently represents a major diagnostic segment because of its ability to provide detailed visualization of cerebral blood vessels.
Treatment options include nimodipine, Triple-H therapy, balloon angioplasty, vasopressors, inotropes, thrombolytic agents, and anti-inflammatory agents. Nimodipine remains an important treatment option, while newer therapeutic approaches are being investigated to improve patient outcomes.
Hospitals represent a major end-user segment because they provide specialized neurological and emergency care. North America currently leads the market, while Asia-Pacific is expected to experience strong growth as healthcare infrastructure and neurological research expand.
Increasing aneurysm incidence, neuroscience research investments, improved diagnostic technologies, and emerging therapies are expected to create opportunities for market participants.